Taiwan Gynecomastia Treatment Market Size & Outlook, 2026-2034
Taiwan Gynecomastia Treatment Market Insights
- According to Reed Intelligence analysis, the Taiwan Gynecomastia Treatment Market size was USD 18.47 Million in 2025 and is projected to reach USD 34.81 Million by 2034.
- The Taiwan market is projected to grow at a CAGR of 7.34% between 2026 and 2034.
- By segment, Surgical emerged as the largest Treatment Type in terms of market size in 2025.
- Non-Surgical is anticipated to remain the most attractive Treatment Type segment, recording the fastest growth during the forecast period.
![Taiwan Gynecomastia Treatment Market Size, Share & Growth Analysis By [2034]](https://reedintelligence.com/uploads/charts/taiwan-gynecomastia-treatment-market-taiwan-treatment-type-89936.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2025, Taiwan held 0.8% of the global Gynecomastia Treatment Market size.
- By 2034, United States is anticipated to capture the largest share of the global Gynecomastia Treatment Market.
- In Asia Pacific, China is expected to lead the regional Gynecomastia Treatment Market size by 2034.
- China will remain the fastest-growing market in Asia Pacific, reaching USD 292.32 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 18.47 Million |
| Market Size In 2034 | USD 34.81 Million |
| Largest segment | Surgical |
| Units | Revenue in USD Million |
| CAGR | 7.34% (2026-2034) |
| Segmnetation Covered | |
| Treatment Type |
|
| End-Use |
|
| Patient Age Group |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Taiwan Gynecomastia Treatment Market Treatment Type 2026-2034 (USD Million)
| Treatment Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical | XX.x | XX.x | XX.x | 11.4 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Non-Surgical | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Taiwan Gynecomastia Treatment Market End-Use 2026-2034 (USD Million)
| End-Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | XX.x | XX.x | XX.x | 9.31 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cosmetic Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ambulatory Surgical Centers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Taiwan Gynecomastia Treatment Market Patient Age Group 2026-2034 (USD Million)
| Patient Age Group | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adolescents | XX.x | XX.x | XX.x | 9.3 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Adults | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Elderly | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
